|
Volumn 66, Issue 6, 2014, Pages 1031-1032
|
Radiobiological modeling and the study of hypofractionated radiotherapy for prostate cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MODEL;
CANCER ADJUVANT THERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SIZE;
CLINICAL RESEARCH;
COST CONTROL;
DOSIMETRY;
EDITORIAL;
HUMAN;
HYPOFRACTIONATED POSTPROSTATECTOMY RADIOTHERAPY;
MALE;
PARTIAL BODY RADIATION;
PATIENT TRANSPORT;
PHASE 2 CLINICAL TRIAL (TOPIC);
PROSTATE CANCER;
RADIATION DOSE ESCALATION;
RADIATION DOSE FRACTIONATION;
RADIATION EXPOSURE;
RADIATION INJURY;
RADIATION RESPONSE;
RESOURCE ALLOCATION;
TREATMENT DURATION;
TREATMENT RESPONSE;
UROGENITAL TRACT DISEASE;
ADVERSE EFFECTS;
BLADDER;
PROSTATIC NEOPLASMS;
RADIATION INJURIES;
SALVAGE THERAPY;
URETHRA;
UROLOGIC DISEASES;
DOSE FRACTIONATION;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
RADIATION INJURIES;
SALVAGE THERAPY;
URETHRA;
URINARY BLADDER;
UROLOGIC DISEASES;
|
EID: 84909977174
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2014.07.036 Document Type: Editorial |
Times cited : (5)
|
References (11)
|